Of course, another key factor weighing in on investors today would be the U.S. Bureau of Labor Statistics’ Consumer Price Index (CPI) report. According to Merck, clinical testing suggests that the pill could half the chances of dying or hospitalization due to severe COVID in at-risk groups. This alongside Pfizer’s (NYSE: PFE) ongoing work with a similar pill continues to highlight the relevance of the biotech industry today.